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Abstract: The relationship between asthma and sleep-disordered breathing is bidirectional due to
common risk factors that promote airway inflammation. Obstructive sleep-disordered breathing
and recurrent wheeze/asthma are conditions that involve the upper and the lower respiratory
system, respectively. The aim of the present study was to investigate the sleep disordered breathing
in children with recurrent wheeze/asthma. This was a retrospective study concerning children
older than 2 years who underwent—between January 2014 and November 2016—an in-laboratory
overnight polygraphic study. We match the children between those who do or do not have recurrent
wheeze/asthma disease. We examined the clinical records of 137 children. We excluded eight patients
because of neurological and genetic conditions. Children with recurrent wheeze/asthma (N = 28) were
younger (p = 0.002) and leaner (p = 0.013) compared to non-affected children (N = 98). Children with
wheeze/asthma and unaffected ones had a similar obstructive apnea-hypopnea index (p = 0.733)
and oxygen desaturation index (p = 0.535). The logistic regression analysis, in which the condition
of wheeze/asthma (yes/no) was a dependent variable, while demographic (age, sex, body mass
index (BMI) Z-score) and polygraphic results during sleep (obstructive apnea-hypopnea index,
central apnea index, peripheral oxygen saturation (SpO2), and snoring) were covariates, showed that
children with wheeze/asthma had higher central apnea index (Exp(B) = 2.212; Wald 6.845; p = 0.009).
In conclusion, children with recurrent wheeze/asthma showed an increased number of central sleep
apneas than unaffected children. This finding may suggest a dysfunction of the breathing control in
the central nervous system during sleep. Systemic or central inflammation could be the cause.
Keywords: asthma; central breathing control; central sleep apnea; children; in-laboratory overnight
respiratory polygraph; obstructive sleep apnea; retrospective study; sleep-disordered breathing
1. Introduction
Obstructive sleep apnea (OSA) is due to a partial or complete cessation of airflow and oxygen
desaturation during sleep [1,2]. The impact on sleep depends partly on the abnormal size of the
airway [3]. In children, the major contributor to airway narrowing is hyperplasia of tonsils and
adenoids [4] and craniofacial disharmony [5].
The polysomnography confirms the clinical notion of obstructive sleep apnea syndrome (OSAS),
also with sleep-disordered breathing (SDB) in asthmatic children [6].
Although children with asthma present a higher risk of SDB, there have still been few sleep
studies reporting on this matter [7]. Specifically, asthma is associated with severe OSAS, and, SDB is
Children 2017, 4, 97; doi:10.3390/children4110097 www.mdpi.com/journal/children
Children 2017, 4, 97 2 of 8
related to severe asthma. Thus, the relationship between asthma and SDB is bidirectional due to
common risk factors that cause airway inflammation [8]. If not attentively controlled, asthmatic
children are at a higher risk of severe OSA [9]. In infancy, recurrent wheeze should be differentiated
with respect to OSAS [10], and it may also lead to an increased risk of developing future asthma [11].
It is still controversial as to whether or not recurrent wheezing develops asthma if considering also
the risk of overestimating or underestimating the symptoms [11]. OSAS and asthma are conditions
that affect the upper and lower respiratory system, respectively. So, OSAS and asthma are both
characterized by an increased nasal obstruction and vagal tone during sleep, and are detrimental to each
other [12]. Recent findings showed that children with OSAS have a significant airway resistance [13],
while asthmatic children show a peripheral airway obstruction during symptom-free periods [14].
Lastly, either OSAS or asthma may affect children’s sleep and respiratory system [15].
Central sleep apneas (CSAs) are physiological in newborns and infants: the upper limit is five
events per hour. The prevalence of asymptomatic upper CSAs reaches 4.1% in children >1 year of age.
Neurological disorders are the main associated conditions [16]. Moreover, an inflammation-mediated
activation (e.g., viral or bacterial infection) induces the release of prostaglandins close to brainstem
cardiorespiratory-related centers. It depresses the autonomic control networks, including the central
drive to breathe during episodes of acute and/or chronic inflammation [17].
The aim of the present study was to investigate the respiratory polysomnographic parameters
that characterize SDB in children with recurrent wheeze/asthma and to compare them to the ones of a
non-disease condition.
2. Materials and Methods
2.1. Study Population
A retrospective study, by review of medical records, concerned children older than 2 years with
an SDB condition who underwent an in-laboratory, overnight polygraphic study in our department of
pediatrics between January 2014 and November 2016.
Reviewed medical records included the in-laboratory overnight polygraphic study and subjects’
age, body growth, asthma, gastroesophageal reflux, as well as genetic and neurological conditions.
Children with genetic conditions/syndromes (achondroplasia, etc.) and/or neurological conditions
(i.e., Arnold-Chiari malformation) were excluded from the study. Moreover, we performed
comparisons between children who had recurrent wheeze/asthma and those who did not. We pooled
together wheezing and asthma in children. The primary criteria to enroll children in pooled patients
was ≥4 episodes of wheezing in one year [11].
The enrolled children referred were from childhood sleep-disordered breathing, pediatric pneumology
ambulatory, or from inpatient settings recovered for wheeze/asthma exacerbation.
The present investigation was based on a preexisting clinical practice, so ethical permission and
informed consent were unnecessary. The study was performed following the Declaration of Helsinki
and under the terms of relevant local legislation.
2.2. Anthropometry
The same trained personnel measured both height and weight using standardized techniques.
We calculated body mass index (BMI; weight (kg)/height (m2)), BMI percentiles, and BMI Z-scores
according to age and sex (http://nccd.cdc.gov/dnpabmi/Calculator.aspx).
2.3. In-Laboratory Overnight Respiratory Polygraph
The in-laboratory overnight respiratory polygraph study (SOMNOscreenTM PSG, SOMNOmedics
GmbH, Randersacker, Germany) monitored nasal airflow, chest and abdominal respiratory movements
(thoracic and abdominal belts), arterial oxygen saturation (SaO2; digital pulse oximetry), heart rate
(HR; finger probe), electrocardiogram (ECG), body position (mercury sensor), and tracheal
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sounds (microphone). We did not use electroencephalogram (EEG), electrooculogram (EOG) or
electromyogram (EMG) techniques. We performed eight channels in the cardiorespiratory assessment
in the cases of a respiratory pathology [18]. We applied the device between 6:00 p.m. and 8:00 a.m.,
and the data were recorded throughout the night. During the test, the children underwent recordings
for ≥6 h in a quiet sleep room accompanied by one of their parents [19]. The total sleep time (TST)
was calculated from the point at which the child fell asleep to the awakening, and it was reported in
a nocturnal diary by the caretaker. No sleep technician was present during the overnight recording.
The nursing staff was trained in the assistance. We considered the nocturnal awakenings from the TST
computation and removed them from the analysis.
The sleep analysis (DOMINO® software, SOMNOmedics v.2.6.0, Randersacker, Germany) of
the entire recording session was manually performed, and some obstructive respiratory events were
reported [20]. In particular, the number of obstructive apneas (OA; events/hour) plus hypopneas
(H; events/hour) was divided by the hours of TST and expressed as an obstructive apnea-hypopnea
index (OAHI; events/hour) [21]. Severe sleep respiratory condition was set at OAHI ≥ 10 events/hour.
We calculated the central apnea index (CAI) as the sum of central respiratory events recorded per hour
of sleep (events/hour TST), as previously reported [22]. In particular, central apnea (CA) was defined
as the absence of nasal airflow and the cessation of respiratory effort, lasting over 20 s or of shorter
duration, if associated with a change in plethysmography, as the surrogate of cortical arousals [23],
and/or a drop ≥3% oxygen (O2) desaturation [16].
We measured the O2 desaturations (≥3%; events/hour) from the baseline, mean peripheral oxygen
saturation (SpO2, %), and smallest SpO2 (%). The oxygen desaturation index (ODI; events/hour) is the
total number of desaturations divided by the TST. We measured the snoring (% of TST) [15] and the
change of position during sleep (events/hour).
2.4. Statistical Analysis
We performed the statistical analysis using SPSS Statistics 22.0® software for Windows.
The frequency of the distributions (%) was calculated for the categorical variables considered in
this study. However, the descriptive statistics (mean, standard deviation (SD)) were calculated for
the quantitative variables. Moreover, the chi-square test was used to explore differences in the
distribution of the categorical variables between the two groups. Mann–Whitney test was used to
explore differences in continuous variables between the two groups. The strength of the association
between the two quantitative variables was evaluated by calculating the simple correlation coefficient
(Pearson’s test). Statistical significance was set at p < 0.05. Binary logistic regression analysis (recurrent
wheeze/asthma yes versus no, as the dependent variable) was performed to assess for correlated
demographic and respiratory polygraph variables.
3. Results
We have examined the clinical records of 134 children, excluding eight patients because of
genetic [6] and neurological diseases [2]. None of the children were born prematurely.
Furthermore, we categorized the children (Table 1) according to the coexistence (16/28 had
confirmed inhalant allergy) and absence (98) of recurrent wheeze/asthma condition, regardless of
whether or not they have had their tonsils and/or adenoids removed (4 versus 18, respectively).
These last 22 children performed the polygraph after surgery to investigate for residual SDB [24].
Children with recurrent wheeze/asthma were under treatment with inhaled corticosteroids; no-one
took intranasal medications.
A summary of the results of the in-laboratory overnight polygraphic studies of the 126 children is
shown in Table 2.
In our sample, children with recurrent wheeze/asthma (N = 28) were younger (p = 0.002) and
leaner (p = 0.013) than non-affected children (N = 98; Table 1). Recurrent wheeze/asthma children
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had a comparable OAHI (p = 0.733) and ODI (p = 0.535), but a higher CAI (p < 0.001) than unaffected
children (Table 2).
Simple correlation analysis (Pearson’s test) between respiratory polygraph variables was
performed to characterize possible correlations (Table 3). In particular, OAHI correlated with ODI in
both (p < 0.001), whereas OAHI correlated with minimum oxygen saturation (SatO2 min) and CAI
only in unaffected children (p < 0.001). Moreover, ODI correlated with snoring only in the asthma
group (p = 0.01). Furthermore, ODI correlated with both SatO2min and CAI only in the not asthma
group (p < 0.001).
Table 1. Summary of the demographic and clinical characteristics of the children enrolled in the study.
Obesity is defined as a BMI at or above the 95th percentile according to age and sex.
Total Patients RecurrentWheeze/Asthma Not Asthma Chi-Square Test
N (%) (p-Value)
Totals (% males) 126 (56.3%) 28 (46.4%) 98 (59.2%) 0.233
Obesity (N (%)) 55 (43.7%) 6 (21.4%) 49 (50%) 0.007
Allergy (N (%)) 34 (27.0%) 16 (57.1%) 18 (18.4%) <0.001
GER (N (%)) 3 (2.4%) 2 (7.1%) 1 (1%) 0.062
Physical Characteristics Mean ± SD Mann–Whitney Test
(p-Value)
Age (years) 7.8 ± 4.1 5.8 ± 3.4 8.4 ± 4.1 0.002
Weight (kg) 39.8 ± 28.3 24.5 ± 14.3 44.2 ± 29.8 0.001
Weight-for-Age Percentiles 76.3 ± 29.0 69.6 ± 26.9 78.2 ± 29.5 0.011
Weight-for-Age Z-score 1.13 ± 1.28 0.70 ± 0.98 1.25 ± 1.33 0.011
Height (cm) 127 ± 25 114.1 ± 20.3 131.3 ± 25.2 0.001
Height-for-Age Percentiles 65.0 ± 28.2 65.0 ± 29.6 65.0 ± 28.0 0.897
Height-for-Age Z-score 0.64 ± 1.2 0.67 ± 1.23 0.64 ± 1.18 0.963
BMI (kg/m2) 21.3 ± 7.1 17.6 ± 2.9 22.4 ± 7.6 0.009
BMI Percentiles 74.9 ± 29.9 68.0 ± 26.8 76.8 ± 30.7 0.011
BMI Z-score 1.1 ± 1.2 0.7 ± 1.0 1.2 ± 1.3 0.013
BMI: body mass index; GER: gastroesophageal reflux; SD: standard deviation.
Table 2. Summary of the in-laboratory overnight polygraphic studies.







Mean ± SD p-Value
eTST (h) 8.8 ± 0.9 9.1 ± 1.0 8.7 ±0.9 0.020
OAHI (N/h) 2.8 ± 5.2 1.7 ± 1.6 3.1 ± 5.8 0.733
CA (N/h) 0.7 ± 0.9 1.3 ±1.3 0.5 ± 0.7 <0.001
ODI (N/h) 2.1 ± 5.7 1.2 ± 1.4 2.3 ± 6.4 0.535
Mean SpO2 (%) 97.7 ± 0.9 97.6 ± 1.0 97.7 ± 0.9 0.914
Min SpO2 (%) 88.3 ± 8.3 87.4 ± 11.8 88.6 ± 7.1 0.580
Snoring (%) 2.2 ± 5.4 1.0 ± 2.4 2.6 ± 6.0 0.038
Change of position (N/h) 3.0 ± 1.8 3.4 ± 1.6 2.9 ± 1.9 0.173
TST: total sleep time; OAHI: obstructive apnea-hypopnea index; CA: central apnea; ODI: oxygen desaturation index;
SpO2: peripheral oxygen saturation.
Table 3. Simple correlation analysis (Pearson’s test) of respiratory polygraphic variables.
Respiratory Polygraph
Variables
Total (N = 126) Recurrent Wheeze/Asthma (N = 28) No Asthma (N = 98)
r (p-Value)
OAHI vs. ODI 0.807 (<0.001) 0.407 (0.032) 0.813 (<0.001)
OAHI vs. SpO2 min −0.250 (0.005) −0.032 (0.873) −0.303 (<0.001)
OAHI vs. snoring 0.038 (0.671) 0.117 (0.552) 0.022 (0.828)
ODI vs. SatO2 min −0.302 (0.001) −0.350 (0.068) −0.378 (<0.001)
ODI vs. Snoring 0.093 (0.298) 0.480 (0.010) 0.076 (0.459)
SatO2: oxygen saturation.
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We did not include two correlated variables (OAHI and ODI) in the computation of regression
analysis. The logistic regression analysis in which recurrent wheeze/asthma (categorical variable:
0 = no, 1 = yes) was a dependent variable, and age, sex, BMI Z-score, OAHI, CAI, mean SpO2, min SpO2,
snoring (%), and change of position, as covariate, showed that the probability of having a high CAI
(Wald 6.845; p = 0.009) is increased in the asthma group (Exp(B) = 2.217). The logistic regression analysis
in which recurrent wheeze/asthma was a dependent variable and age, sex, BMI Z-score, ODI, CAI,
mean SpO2, min SpO2, snoring (%) and change of position as covariate showed that the probability of
having a high CAI (Wald 6.614; p = 0.010) is increased in the asthma group (Exp(B) = 2.182).
Figure 1 shows the simple linear regression analysis between CAI and age of both children with
recurrent wheeze/asthma (red circle) and unaffected ones (black circle). This graphic may suggest that
the CAI is higher in children with recurrent wheeze/asthma than in unaffected ones.
In a subgroup of 21 children with recurrent wheeze/asthma and 38 unaffected children,
matched for age (4.2± 1.4 years versus 4.9± 1.6 years, respectively; p = not significant (NS)) and OAHI
(1.8± 1.4 events/hour versus 1.7± 1.4 events/hour, respectively; p = NS), the test U of Mann–Whitney
showed a higher CAI in the former (1.5 ± 1.4 events/hour versus 0.5 ± 0.8 events/hour; p = 0.013).
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Figure 1. Plotted distr bution with regres ion lin een central apnea index (CAI) and age of the
126 children categorized with recu rent wheeze/asthma (red cir le, N = 28) or no -asthma (black circle,
N = 98) condition.
4. Discus ion
The main findings of the present study were that children with recurrent wheeze/asthma showed
an increased number of CSAs compared to unaffected children. Recurrent wheeze/asthma mildly
affected the CAI in these children. A sampling of affected and unaffected children, balanced for age
and SDB severity, may confirm this observation.
CSA is the absence of chest and abdominal movement, associated with cessation of nasal airflow:
the duration of the occurrence is about 20 s or more; if not, it may occur for at least two baseline
respiratory cycles and is then associated with an arousal, an awakening, or an xyg n desaturation of
at least 3% [20]. T e CAI is the number of CSA per hour of sleep [20]. The author we e supporting the
opinion that a CAI > 5 events/hour represents a significant central sleep apnea sy drome (CSAS) [25].
A CAI between 1 event/hour and 5 events/hour is mild CSAS [26]. CSAS can be primary or associated
with medical conditions including brainstem pathology [27], heart failure, and prematurity. Therefore,
Sholle et al. reported the normative values of CSAs in groups of children with different ages [22].
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This method seems to improve sleep pathology identification. Unfortunately, we did not determine
central events related to sleep stages because we have not interpreted a proper reading of such events.
A full polysomnography (with EEG) could be more helpful in this context in a further prospective
protocol design.
Emerging case studies showed that OSAS and CSAs are related. In particular, a CAI ≥ 1 event/hour
is more common in children with OSAS, while CSAS (CAI > 5 events/hour) is rare. Moreover, it a
significant decrease in the mild CAI after (adeno)tonsillectomy has been observed (preoperative
CAI 3.9 ± 2.9 events/hour; postoperative CAI 1.9 ± 4.8 events/hour) [28]. Evidence illustrates an
overlap between CSAS and OSAS, including elevated loop gain in patients with OSAS and pharyngeal
narrowing during CSAs [29]. Children with asthma occasionally present CSAS [25].
Although the exact cause of CSAS is unknown, this condition likely disrupts the breathing control
of the central nervous system [30]. Behavioral factors are largely eliminated during non-REM sleep,
leaving the control of breathing to metabolic factors. Partial pressure of carbon dioxide (PaCO2)
becomes the only stimulus for ventilation during sleep. Respiration-induced changes in the PaCO2
play a key role in regulating cerebral blood flow. Alterations in cerebral blood flow triggered by
changes in PaCO2 are referred to as cerebrovascular reactivity. Children with asthma may experience
nocturnal hypoxemia and hypoventilation [31]. In addition, inflammation and remodeling of the
airway [32], oxidative stress [33], and systemic inflammation [34–36] are reported in asthma patients.
Oxidative stress ensues in diverse forms, producing complex structural and functional changes that
have implications on cerebral perfusion and permeability of the blood–brain barrier [37,38]. On these
bases, we hypothesized that children with asthma may have an increased/additive risk of abnormal
central control of the respiration compared to SDB children without recurrent wheeze/asthma.
Nevertheless, the study has several limitations. Inclusion criteria of the polygraph test could affect
the results, considering that parents of children with asthma/wheeze may have a tendency to address
the problem of sleep disturbance by seeking medical help. We could have a false higher proportion of
asthmatics with SDB. In our cohort, 22% are asthmatic, which was higher than expected in this age
group, with consequent recruitment bias. In light of this limitation, a prospective study which analyses
asthmatic versus non-asthmatic subjects could control this bias. Another limitation of the present study
was its retrospective nature. The two selected samples had different ages and SDB severity. Therefore,
children beyond two years of age have an increased stability of oxygenation and more stable lung
volume [15]. Another limitation of this study is the assessment of the cardiorespiratory analysis during
sleep. Sleep stages were not performed, and sleep time was extrapolated according to the caretaker’s
statements. Thus, the wakefulness may have been scored as sleep and vice versa [39]. Finally, we
pooled together infant wheezing and asthmatic children, even though not all wheeze children would
have developed asthma [11].
In conclusion, children with recurrent wheeze/asthma have increased CAI. This finding may
suggest a dysfunction of the breathing control in the central nervous system during sleep. We speculate
that systemic or central inflammation could be the cause.
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